Amgen price target raised to $430 by RBC Capital
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
02:50:29 PM UTC
SquawkNews
Amgen Price Target Raised to $430.00/Share From $400.00 by RBC Capital